Metastatic non-small cell lung cancer: costs associated with disease progression.
about
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary DepartmentCost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung CancerCost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.Cost of Tobacco-related Cancer Hospitalizations in the U.S., 2014.
P2860
Metastatic non-small cell lung cancer: costs associated with disease progression.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Metastatic non-small cell lung cancer: costs associated with disease progression.
@en
Metastatic non-small cell lung cancer: costs associated with disease progression.
@nl
type
label
Metastatic non-small cell lung cancer: costs associated with disease progression.
@en
Metastatic non-small cell lung cancer: costs associated with disease progression.
@nl
prefLabel
Metastatic non-small cell lung cancer: costs associated with disease progression.
@en
Metastatic non-small cell lung cancer: costs associated with disease progression.
@nl
P2093
P1476
Metastatic non-small cell lung cancer: costs associated with disease progression
@en
P2093
Jennifer Kim
John M Brooks
Kathleen M Fox
P304
P577
2008-09-01T00:00:00Z